Trump policies disrupting trials at NIH Clinical Center

Studies of new treatments have been delayed at the hospital focused on hard-to-treat diseases.

May 6, 2025 Check out STAT+

Sponsored By

NIH STAT+ | Trump policies disrupt trials at NIH Clinical Center, researchers say Staff shortages and new rules slow NIH Clinical Center trials, deterring biotech partners, impacting studies for patients with rare diseases By Jonathan Wosen and Jason Mast STAT+ | Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out. By Lizzy Lawrence, Jason Mast, and Matthew Herper STAT+ | Trump signs order in bid to boost pharma manufacturing in the U.S. Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants. By Ed Silverman Adobe Opinion: The entire U.S. health care system must be torn down and rebuilt The Trump administration's downsizing of HHS is a good start to remaking the entire system to Americans' benefit. By Charles M. Silver Opinion: How to stop the shift of drug discovery from the U.S. to China U.S. drug firms license compounds from China due to lower costs, faster trials. Former FDA commissioner says regulatory reform needed to stay competitive. By Scott Gottlieb STAT+ | Few drugmakers embrace a newer test for contamination, placing horseshoe crabs at risk The pharmaceutical industry has long relied on a test that uses a protein called LAL taken from the blood of American horseshoe crabs. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser